Edwin Reisz Sells 17,613 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Edwin Reisz sold 17,613 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $7.85, for a total value of $138,262.05. Following the completion of the transaction, the insider owned 1,321,114 shares in the company, valued at $10,370,744.90. This represents a 1.32% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Aveanna Healthcare Price Performance

NASDAQ AVAH opened at $8.08 on Friday. The company has a 50 day moving average price of $8.92 and a two-hundred day moving average price of $7.51. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.67 and a 12-month high of $10.32. The stock has a market capitalization of $1.69 billion, a PE ratio of 22.44 and a beta of 2.06. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. The business had revenue of $450.53 million for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. As a group, equities analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aveanna Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of AVAH. JPMorgan Chase & Co. increased its position in Aveanna Healthcare by 32.4% during the third quarter. JPMorgan Chase & Co. now owns 209,491 shares of the company’s stock worth $1,858,000 after acquiring an additional 51,226 shares during the period. Caxton Associates LLP bought a new position in shares of Aveanna Healthcare during the 3rd quarter worth about $488,000. PharVision Advisers LLC increased its holdings in shares of Aveanna Healthcare by 37.6% during the 3rd quarter. PharVision Advisers LLC now owns 20,595 shares of the company’s stock worth $183,000 after purchasing an additional 5,630 shares during the period. XTX Topco Ltd acquired a new position in shares of Aveanna Healthcare during the third quarter valued at about $531,000. Finally, Voleon Capital Management LP bought a new stake in shares of Aveanna Healthcare in the third quarter valued at about $2,949,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on AVAH. Jefferies Financial Group raised their price objective on Aveanna Healthcare from $11.00 to $12.50 and gave the company a “buy” rating in a research note on Tuesday, October 28th. Raymond James Financial reissued an “outperform” rating and issued a $13.00 price target on shares of Aveanna Healthcare in a research report on Friday, December 5th. JPMorgan Chase & Co. upgraded shares of Aveanna Healthcare from an “underweight” rating to a “neutral” rating and boosted their price objective for the stock from $6.00 to $10.00 in a research note on Thursday, September 18th. Truist Financial raised their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research note on Friday, November 7th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Monday, December 29th. Five equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $10.69.

Aveanna Healthcare News Summary

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.